These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action. Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243 [TBL] [Abstract][Full Text] [Related]
3. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene. Bayerer B; Stamer U; Hoeft A; Stüber F Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022 [TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732 [TBL] [Abstract][Full Text] [Related]
5. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. Oertel BG; Kettner M; Scholich K; Renné C; Roskam B; Geisslinger G; Schmidt PH; Lötsch J J Biol Chem; 2009 Mar; 284(10):6530-5. PubMed ID: 19116204 [TBL] [Abstract][Full Text] [Related]
6. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers. Lötsch J; Geisslinger G Pharmacogenomics J; 2006; 6(3):200-10. PubMed ID: 16415919 [TBL] [Abstract][Full Text] [Related]
7. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers. Oertel BG; Schmidt R; Schneider A; Geisslinger G; Lötsch J Pharmacogenet Genomics; 2006 Sep; 16(9):625-36. PubMed ID: 16906017 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoepigenetics of the role of DNA methylation in μ-opioid receptor expression in different human brain regions. Knothe C; Oertel BG; Ultsch A; Kettner M; Schmidt PH; Wunder C; Toennes SW; Geisslinger G; Lötsch J Epigenomics; 2016 Dec; 8(12):1583-1599. PubMed ID: 27685027 [TBL] [Abstract][Full Text] [Related]
9. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions. Xu J; Lu Z; Xu M; Pan L; Deng Y; Xie X; Liu H; Ding S; Hurd YL; Pasternak GW; Klein RJ; Cartegni L; Zhou W; Pan YX J Neurosci; 2014 Aug; 34(33):11048-66. PubMed ID: 25122903 [TBL] [Abstract][Full Text] [Related]
10. Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Drakenberg K; Nikoshkov A; Horváth MC; Fagergren P; Gharibyan A; Saarelainen K; Rahman S; Nylander I; Bakalkin G; Rajs J; Keller E; Hurd YL Proc Natl Acad Sci U S A; 2006 May; 103(20):7883-8. PubMed ID: 16682632 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients. Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240 [TBL] [Abstract][Full Text] [Related]
12. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Shi J; Hui L; Xu Y; Wang F; Huang W; Hu G Hum Mutat; 2002 Apr; 19(4):459-60. PubMed ID: 11933204 [TBL] [Abstract][Full Text] [Related]
13. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Zhang D; Shao C; Shao M; Yan P; Wang Y; Liu Y; Liu W; Lin T; Xie Y; Zhao Y; Lu D; Li Y; Jin L Biol Psychiatry; 2007 Jun; 61(11):1244-51. PubMed ID: 17157823 [TBL] [Abstract][Full Text] [Related]
14. Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. Woodcock EA; Lundahl LH; Burmeister M; Greenwald MK Am J Addict; 2015 Jun; 24(4):329-35. PubMed ID: 25911999 [TBL] [Abstract][Full Text] [Related]
15. Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population. Xu J; Wang T; Su Z; Zhou X; Xiang Y; He L; Li C; Yang Z; Zhao X Biochem Genet; 2018 Oct; 56(5):451-458. PubMed ID: 29564682 [TBL] [Abstract][Full Text] [Related]
16. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians. Daher M; Costa FM; Neves FA Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975 [TBL] [Abstract][Full Text] [Related]
17. No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Nikolov MA; Beltcheva O; Galabova A; Ljubenova A; Jankova E; Gergov G; Russev AA; Lynskey MT; Nelson EC; Nesheva E; Krasteva D; Lazarov P; Mitev VI; Kremensky IM; Kaneva RP; Todorov AA Drug Alcohol Depend; 2011 Aug; 117(1):62-5. PubMed ID: 21277709 [TBL] [Abstract][Full Text] [Related]
18. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. Chorbov VM; Todorov AA; Lynskey MT; Cicero TJ J Opioid Manag; 2011; 7(4):258-64. PubMed ID: 21957825 [TBL] [Abstract][Full Text] [Related]
19. Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain. Doehring A; Oertel BG; Sittl R; Lötsch J Pain; 2013 Jan; 154(1):15-23. PubMed ID: 23273101 [TBL] [Abstract][Full Text] [Related]
20. Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Hancock DB; Levy JL; Gaddis NC; Glasheen C; Saccone NL; Page GP; Hulse GK; Wildenauer D; Kelty EA; Schwab SG; Degenhardt L; Martin NG; Montgomery GW; Attia J; Holliday EG; McEvoy M; Scott RJ; Bierut LJ; Nelson EC; Kral AH; Johnson EO Biol Psychiatry; 2015 Oct; 78(7):474-84. PubMed ID: 25744370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]